Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up

CompletedOBSERVATIONAL
Enrollment

1,481

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

October 31, 2014

Conditions
Coronary Heart DiseaseHeart FailureHIVAIDSMetabolic Syndrome
Interventions
OTHER

Comprehensive non invasive cardiovascular examination

"* Anamnesis with the participian~* File recherche,Physical examination~* Documentation of the carciovascular and antiretroviral medical therapy~* Electrocardiogram~* Transthoracic echocardiography~* Exercise electrocardiogram~* Measuring of the arterial media thickness~* Exercise Montreal Cognitive Assesment test~* Exercise the Grooved Pegboard test~* Blood collection~* Questionnaire to quality of life and health economics"

Trial Locations (6)

44137

HIV Outpatient Department, Dortmund

44791

University Hospital of Bochum, Department of Dermatology, Bochum

45147

University Hospital, Department of Dermatology and Venerology, Essen

University Hospital, West German Heart Center Essen, Essen

47249

Health Center, Duisburg

04107

Clinical Coordinating Center Leipzig, Leipzig

All Listed Sponsors
collaborator

HIV-HEART Study Investigative Group

UNKNOWN

collaborator

German Heart Failure Network

OTHER

collaborator

German Federal Ministry of Education and Research

OTHER_GOV

collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

ViiV Healthcare

INDUSTRY

collaborator

Gilead Sciences

INDUSTRY

collaborator

Janssen-Cilag GmbH

UNKNOWN

collaborator

Abbott

INDUSTRY

collaborator

Boehringer Ingelheim

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University Hospital, Essen

OTHER